Literature DB >> 33663517

Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis.

Xi Li1, Yan Duan2, Yuxia Hao3.   

Abstract

BACKGROUND: The pathogenesis of germinal center B-cell type diffuse large B-cell lymphoma (GCB-DLBCL) is not fully elucidated. This study aims to explore the regulation of super enhancers (SEs) on GCB-DLBCL by identifying specific SE-target gene.
METHODS: Weighted gene co-expression network analysis (WGCNA) was used to screen modules associated with GCB subtype. Functional analysis was performed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. H3K27ac peaks were used to identify SEs. Overall survival analysis was performed using Kaplan-Meier curve with log-rank and Breslow test. The effect of ADNP, ANKRD28 and RTN4IP1 knockdown on Karpas 422 and SUDHL-4 cells proliferation was analyzed by CCK-8. Karpas 422 and SUDHL-4 cells were treated with bromodomain and extra-terminal domain (BET) inhibitor JQ1, and the expression of ADNP, ANKRD28 and RTN4IP1was measured by qRT-PCR.
RESULTS: A total of 26 modules were screened in DLBCL. Turquoise module was closely related to GCB-DLBCL, and its eigengenes were mainly related to autophagy. There were 971 SEs in Karpas 422 cell and 1088 SEs in SUDHL-4 cell. Function of the nearest genes of overall SEs were related to cancer. Six SE-related genes associated with GCB-DLBCL were identified as prognostic markers. Knockdown of ADNP, ANKRD28 and RTN4IP1 inhibited the proliferation of Karpas 422 and SUDHL-4 cells. JQ1 treatment suppressed ADNP, ANKRD28 and RTN4IP1 expression in Karpas 422 and SUDHL-4 cells.
CONCLUSIONS: A total of 6 SE-related genes associated with GCB-DLBCL overall survival were identified in this study. These results will serve as a theoretical basis for further study of gene regulation and function of GCB-DLBCL.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; Germinal center B-cell type; Overall survival; Super enhancers; Weighted gene co-expression network analysis

Year:  2021        PMID: 33663517      PMCID: PMC7934469          DOI: 10.1186/s12920-021-00916-z

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  33 in total

1.  Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma.

Authors:  Nikhil A Sangle; Rodney R Miles; Todd W Kelley; Sherrie L Perkins
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 Nov-Dec

2.  What are super-enhancers?

Authors:  Sebastian Pott; Jason D Lieb
Journal:  Nat Genet       Date:  2015-01       Impact factor: 38.330

3.  Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.

Authors:  H J M de Jonge; C M Woolthuis; A Z Vos; A Mulder; E van den Berg; P M Kluin; K van der Weide; E S J M de Bont; G Huls; E Vellenga; J J Schuringa
Journal:  Leukemia       Date:  2011-07-15       Impact factor: 11.528

4.  A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia.

Authors:  Maho Ishikawa; Fumiharu Yagasaki; Daisuke Okamura; Tomoya Maeda; Yuichi Sugahara; Itsuro Jinnai; Masami Bessho
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

5.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 6.  Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective.

Authors:  N M Reddy; C Thieblemont
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

7.  Dissection of thousands of cell type-specific enhancers identifies dinucleotide repeat motifs as general enhancer features.

Authors:  J Omar Yáñez-Cuna; Cosmas D Arnold; Gerald Stampfel; Lukasz M Boryń; Daniel Gerlach; Martina Rath; Alexander Stark
Journal:  Genome Res       Date:  2014-04-08       Impact factor: 9.043

8.  A specific gene expression signature for visceral organ metastasis in breast cancer.

Authors:  C D Savci-Heijink; H Halfwerk; J Koster; H M Horlings; M J van de Vijver
Journal:  BMC Cancer       Date:  2019-04-08       Impact factor: 4.430

9.  Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.

Authors:  Demeng Chen; Zhiqiang Zhao; Zixin Huang; Du-Chu Chen; Xin-Xing Zhu; Yi-Ze Wang; Ya-Wei Yan; Shaojun Tang; Subha Madhavan; Weiyi Ni; Zhan-Peng Huang; Wen Li; Weidong Ji; Huangxuan Shen; Shuibin Lin; Yi-Zhou Jiang
Journal:  Bone Res       Date:  2018-04-04       Impact factor: 13.567

10.  Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype.

Authors:  Antonio Vogelsberg; Julia Steinhilber; Barbara Mankel; Birgit Federmann; Janine Schmidt; Ivonne A Montes-Mojarro; Katrin Hüttl; Maria Rodriguez-Pinilla; Praveen Baskaran; Sven Nahnsen; Miguel A Piris; German Ott; Leticia Quintanilla-Martinez; Irina Bonzheim; Falko Fend
Journal:  Haematologica       Date:  2020-08-27       Impact factor: 9.941

View more
  2 in total

1.  Vineland Adaptive Behavior Scale in a Cohort of Four ADNP Syndrome Patients Implicates Age-Dependent Developmental Delays with Increased Impact of Activities of Daily Living.

Authors:  Joseph Levine; Fahed Hakim; R Frank Kooy; Illana Gozes
Journal:  J Mol Neurosci       Date:  2022-08-03       Impact factor: 2.866

2.  A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.

Authors:  Hong Xu; Yuhang Li; Yanan Jiang; Jinhuan Wang; Huimeng Sun; Wenqi Wu; Yangyang Lv; Su Liu; Yixin Zhai; LinYan Tian; Lanfang Li; Zhigang Zhao
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.